Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects

GSK Investigational Site, New York

GSK Investigational Site, Philadelphia

GSK Investigational Site, Baltimore

GSK Investigational Site, Richmond

GSK Investigational Site, Richmond

GSK Investigational Site, Norfolk

GSK Investigational Site, Winston-Salem

GSK Investigational Site, Salisbury

GSK Investigational Site, Charlotte

GSK Investigational Site, Wilmington

GSK Investigational Site, Hickory

GSK Investigational Site, Statesville

GSK Investigational Site, Suwanee

GSK Investigational Site, Atlanta

GSK Investigational Site, Dunwoody

GSK Investigational Site, Hollywood

GSK Investigational Site, Tampa

GSK Investigational Site, Pinellas Park

GSK Investigational Site, Mobile

GSK Investigational Site, Bristol

GSK Investigational Site, Louisville

GSK Investigational Site, Cincinnati

GSK Investigational Site, Cincinnati

GSK Investigational Site, Indianapolis

GSK Investigational Site, Bloomington

GSK Investigational Site, Evansville

GSK Investigational Site, Edina

GSK Investigational Site, Chicago

GSK Investigational Site, Wentzville

GSK Investigational Site, Kansas City

GSK Investigational Site, Plano

GSK Investigational Site, San Antonio

GSK Investigational Site, Thousand Oaks

GSK Investigational Site, Encinitas

GSK Investigational Site, Fresno

GSK Investigational Site, Greenbrae

GSK Investigational Site, Sacramento

GSK Investigational Site, Seattle

GSK Investigational Site, Lakewood

GSK Investigational Site, Warwick